Humulin R, 100 IU/ml
(Human Insulin)
Humulin R contains human insulin as the active substance, which is used to treat diabetes.
The cause of diabetes is the pancreas's inability to produce insulin in amounts that allow
control of blood glucose levels. Humulin R is used to control blood glucose levels in the long term.
Humulin R is a fast-acting insulin.
The doctor may recommend using Humulin R and insulin with a longer duration of action.
A different leaflet for the patient is provided for each type of insulin. Do not change insulin unless
your doctor recommends it. When changing insulin, be very careful. Each type of insulin has a different
symbol and color on the packaging and cartridge to make it easier to distinguish.
Before starting to use Humulin R, talk to your doctor, pharmacist, or nurse.
Skin changes at the injection site
It is necessary to change the injection site to prevent skin changes, such as lumps under the skin. Insulin injected into an area with lumps may not work properly (see "How to use Humulin R"). If insulin is currently being injected into an area with lumps, consult a doctor before changing it. The doctor may recommend closer monitoring of blood glucose levels and adjusting the dose of insulin or other diabetes medicines.
Tell your doctor or pharmacist about all medicines you are taking or have recently taken, as well as any medicines you plan to take.
The body's need for insulin may change when using:
The body's need for insulin usually decreases during the first three months of pregnancy and increases over the next six months. In breastfeeding women, it may be necessary to adjust the dose of insulin or diet.
If you are pregnant or breastfeeding, think you may be pregnant, or plan to have a baby, ask your doctor or pharmacist for advice before using this medicine.
In case of hypoglycemia (low blood glucose), the patient's ability to concentrate and react may be impaired. This should be kept in mind in all situations where it could be a hazard for the patient or others (e.g., when driving a car or operating machinery). Consult a diabetes nurse or doctor about driving if:
This medicine contains less than 1 mmol of sodium (23 mg) per dose, which is essentially "sodium-free".
This medicine should always be used according to the doctor's or pharmacist's recommendations. In case of doubts, consult a doctor or pharmacist. To avoid the risk of transmitting diseases, each cartridge can only be used by one person, even if the needle has been changed.
Humulin R should be injected according to the doctor's or diabetes nurse's instructions.
If a higher dose of Humulin R than recommended is used, low blood glucose may occur. Check your blood glucose level (see subsection A in section 4)
If a lower dose of Humulin R than recommended is used, high blood glucose may occur. Check your blood glucose level. Do not inject a double dose to make up for a missed dose.
If a lower dose of Humulin R than recommended is used, high blood glucose may occur. Do not change your insulin unless your doctor recommends it.
In case of any further doubts about using this medicine, consult a doctor, pharmacist, or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Generalized allergic reactionsare very rare (less than 1 in 10,000 patients). The symptoms are:
If you experience any of these symptoms while using Humulin R, contact a doctor immediately.
Local allergic reactionsare common (less than 1 in 10 patients). The symptom may be redness, swelling, or itching of the skin around the injection site. These symptoms usually go away after a few days or weeks. If you experience any of these symptoms, tell your doctor.
If insulin is injected into the same spot too often, the fatty tissue may shrink (lipoatrophy) or thicken (lipohipertrophy) (less than 1 in 100 patients).
Lumps under the skin can also be caused by the accumulation of a protein called amyloid (amyloidosis of the skin, frequency unknown). Insulin injected into an area with lumps may not work properly. Always change the injection site to prevent these skin changes.
Swelling (e.g., swelling of the arms, ankles; fluid retention) has been reported, especially at the start of insulin therapy or when changing treatment to improve blood glucose control.
Hypoglycemia (low blood glucose) is a condition in which there is too little glucose in the blood. It can occur if:
Alcohol and some medicines can affect blood glucose levels.
The first symptoms of low blood glucose usually appear quickly and include:
If you are not sure about recognizing the warning signs of hypoglycemia, avoid situations where you could put yourself or others at risk (e.g., driving a car).
If your blood glucose level is low, eat glucose tablets, sugar, or a sweet drink. Then eat fruit, biscuits, or a sandwich, as recommended by your doctor, and rest. This usually works for mild hypoglycemia or a small overdose of insulin. If your condition worsens, and you experience shallow breathing, and your skin becomes pale, contact a doctor immediately. An injection of glucagon may help in cases of severe hypoglycemia. After injecting glucagon, eat glucose tablets or sugar. If you do not improve after glucagon injection, go to the hospital. Ask your doctor for information about glucagon.
Hyperglycemia (high blood glucose) means that the body is not getting enough insulin. Hyperglycemia can be caused by:
Hyperglycemia can lead to diabetic ketoacidosis. The first symptoms develop slowly over several hours or days. They include:
Severe symptoms include difficulty breathing and rapid pulse. Seek medical help immediately.
Untreated hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) can lead to serious complications and cause headaches, nausea, vomiting, dehydration, loss of consciousness, coma, or even death.
Three simple waysto avoid hypoglycemia or hyperglycemia:
During illness, especially if you have diarrhea or vomiting, your need for insulin may change. People with diabetes need insulin even if they are not eating their normal meals.Perform a urine or blood test, follow the general rules for treating illness, and contact a diabetes nurse or doctor.
If you experience any side effects, including any not listed in this leaflet, tell your doctor, pharmacist, or nurse. Side effects can be reported directly to the Department of Drug Safety, Office for Registration of Medicinal Products, Medical Devices, and Biocidal Products: Al. Jerozolimskie 181C, 02-222 Warsaw, tel.: +48 22 49 21 301, fax: +48 22 49 21 309, website: https://smz.ezdrowie.gov.pl .
Side effects can also be reported to the marketing authorization holder or its representative. By reporting side effects, you can help provide more information on the safety of this medicine.
Keep the medicine out of the sight and reach of children.
Before first use, store Humulin R in a refrigerator (2°C - 8°C). Do not freeze.
The used pen and cartridge should be kept at room temperature (below 30°C) and used within 28 days. Do not store the used pen or cartridges in a refrigerator.
Do not put them near heat sources or in direct sunlight.
Do not use this medicine after the expiry date stated on the label and carton. The expiry date refers to the last day of that month.
Do not use this medicine if you notice it is discolored or particles are visible.
Humulin R can only be used if it looks like water. Check the appearance of the insulin before each injection.
Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.
Humulin R is a clear, colorless, sterile, aqueous solution of human insulin.
One milliliter of the solution contains 100 international units (100 IU/ml) of insulin.
Each cartridge contains 300 units (3 ml of solution).
Cartridges are sold in packs of 5.
Marketing authorization holder:
Eli Lilly Nederland B.V., Papendorpseweg 83, 3528 BJ Utrecht, Netherlands
Manufacturer:
Lilly France S.A.S., Rue du Colonel Lilly, 67640 Fegersheim, France
Eli Lilly Italia S.p.A., Via A. Gramsci 731-733, 50019 Sesto Fiorentino, Italy
To obtain more detailed information, contact the representative of the marketing authorization holder:
Eli Lilly Polska Sp.z o.o.
ul. Żwirki i Wigury 18A
02-092 Warsaw
Tel: +48 22 440 33 00
Huminsulin "Lilly" Normal (Austria)
Umuline Rapide 100 UI/ml (France)
Humuline Regular (Belgium, Luxembourg, Netherlands)
Huminsulin Normal für Pen 3 ml (Germany)
Humulin Regular (Cyprus, Greece, Portugal, Sweden)
Humulin S (Malta, Ireland, United Kingdom)
Humulin R (Bulgaria, Croatia, Estonia, Hungary, Latvia, Lithuania, Italy, Poland, Romania, Slovenia)
Humulin R Cartridge (Czech Republic, Slovakia)
Need help understanding this medicine or your symptoms? Online doctors can answer your questions and offer guidance.